"Designing Growth Strategies is in our DNA"

U.S. Interventional Oncology Market Size, Share & COVID-19 Impact Analysis, By Type (Radiation Therapy, Ablation Devices {Microwave Ablation, Radiofrequency Ablation, Cryoablation, and Others}, and Particle Embolization Devices {Microcatheters and Guidewires}), By Cancer Type (Lung Cancer, Liver Cancer, Kidney Cancer, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Country Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI109199

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Cancer Diseases, in the U.S., 2022
    2. Key Industry Developments (Mergers, Acquisitions, Partnerships)
    3. Overview: Technological Advancements in Interventional Oncology
    4. Impact of COVID-19 on the Market
  5. U.S. Interventional Oncology Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Type
      1. Radiation Therapy Devices
      2. Ablation Devices
        1. Microwave Ablation
        2. Radiofrequency Ablation
        3. Cryoablation
        4. Other
      3. Particle Embolization Devices
        1. Microcatheters
        2.  Guidewires
      4. Market Analysis, Insights and Forecast – By Cancer Type
        1. Lung Cancer
        2. Liver Cancer
        3. Kidney Cancer
        4. Others
      5. Market Analysis, Insights and Forecast – By End-user
        1. Hospitals
        2. Specialty Clinics
        3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Boston Scientific Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Merit Medical Systems
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Terumo Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Siemens Healthcare GmbH
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. BD
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. AngioDynamics
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Hologic, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Teleflex Incorporated
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: U.S. Interventional Oncology Market Revenue Breakdown (USD million, %) by Region, 2022 & 2030

Figure 2: U.S. Interventional Oncology Market Value Share (%), by Type, 2022 & 2030

Figure 3: U.S. Interventional Oncology Market Value Share (%), By Cancer Type, 2022 & 2030

Figure 4: U.S. Interventional Oncology Market Value Share (%), by End-user, 2022 & 2030

Figure 5: U.S. Interventional Oncology Market Share (%), By Company, 2022

Table 1: U.S. Interventional Oncology Market Revenue (USD million) Forecast, by Type, 2019–2030

Table 2: U.S. Interventional Oncology Market Revenue (USD million) Forecast, Ablation Devices, 2019–2030

Table 3: U.S. Interventional Oncology Market Revenue (USD million) Forecast, Embolization Devices, 2019–2030

Table 4: U.S. Interventional Oncology Market Revenue (USD million) Forecast, By Cancer Type, 2019–2030

Table 5: U.S. Interventional Oncology Market Revenue (USD million) Forecast, by End-user, 2019–2030

  • 2019-2030
  • 2022
  • 2019-2021
  • 70
Consulting Services
    How will you benefit from our consulting services ?